Interpace Biosciences, Inc. financial data

Symbol
IDXG on OTC
Industry
Surgical & Medical Instruments & Apparatus
Location
Waterview Plaza, Suite 310, 2001 Route 46, Parsippany, NJ
State of incorporation
DE
Fiscal year end
December 31
Former names
Interpace Diagnostics Group, Inc. (to 11/1/2019), PDI INC (to 12/22/2015), PROFESSIONAL DETAILING INC (to 11/13/2002)
Latest financial report
10-Q - Q3 2024 - Nov 8, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 55.2 % -39.2%
Quick Ratio 6.51 % -24.7%
Debt-to-equity -44.1 % +12.7%
Return On Equity -7.85 % -398%
Return On Assets 36 %
Operating Margin -63.7 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 4.4M shares +1.92%
Common Stock, Shares, Outstanding 4.4M shares +1.92%
Entity Public Float 3.79M USD -67.3%
Common Stock, Value, Issued 406K USD +0.25%
Weighted Average Number of Shares Outstanding, Basic 4.39M shares +1.71%
Weighted Average Number of Shares Outstanding, Diluted 4.42M shares +2.41%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 5.68M USD
Revenue from Contract with Customer, Excluding Assessed Tax 44.9M USD +17.3%
Cost of Revenue 17.7M USD +14.6%
Research and Development Expense 634K USD +13%
Selling and Marketing Expense 11.4M USD +18.5%
General and Administrative Expense 8.77M USD -11%
Operating Income (Loss) 6.35M USD +311%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 4.9M USD
Income Tax Expense (Benefit) 17K USD -5.56%
Net Income (Loss) Attributable to Parent 4.7M USD
Earnings Per Share, Basic 1.08 USD/shares
Earnings Per Share, Diluted 1.07 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 2.11M USD -58%
Accounts Receivable, after Allowance for Credit Loss, Current 7.29M USD +51%
Inventory, Net 1.22M USD +11.6%
Other Assets, Current 1.7M USD +8.12%
Assets, Current 11.1M USD -2.87%
Property, Plant and Equipment, Net 1.35M USD +77.4%
Operating Lease, Right-of-Use Asset 1.53M USD -22.5%
Goodwill 8.43M USD 0%
Other Assets, Noncurrent 45K USD 0%
Assets 14M USD -1.48%
Accounts Payable, Current 1.7M USD +25.8%
Employee-related Liabilities, Current 1.69M USD +29.9%
Liabilities, Current 18.8M USD +52.3%
Long-term Debt and Lease Obligation 1.75M USD -41.1%
Operating Lease, Liability, Noncurrent 1.19M USD -23.6%
Other Liabilities, Noncurrent 5.23M USD +5.62%
Liabilities 25.2M USD -17.1%
Retained Earnings (Accumulated Deficit) -244M USD +1.89%
Stockholders' Equity Attributable to Parent -57.7M USD +7.97%
Liabilities and Equity 14M USD -1.48%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -58K USD -105%
Net Cash Provided by (Used in) Financing Activities -600K USD -100%
Net Cash Provided by (Used in) Investing Activities -28K USD +56.9%
Common Stock, Shares Authorized 100M shares 0%
Common Stock, Shares, Issued 4.53M shares +2.85%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -686K USD -189%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 2.11M USD -58%
Deferred Tax Assets, Valuation Allowance 38.7M USD +1.04%
Operating Lease, Liability 1.49M USD -24.2%
Payments to Acquire Property, Plant, and Equipment 28K USD -56.9%
Lessee, Operating Lease, Liability, to be Paid 1.88M USD -27.1%
Property, Plant and Equipment, Gross 3.33M USD +16.6%
Operating Lease, Liability, Current 305K USD -26.3%
Lessee, Operating Lease, Liability, to be Paid, Year Two 450K USD 0%
Lessee, Operating Lease, Liability, to be Paid, Year One 450K USD -21.7%
Operating Lease, Weighted Average Discount Rate, Percent 0.12 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 386K USD -36.6%
Lessee, Operating Lease, Liability, to be Paid, Year Three 550K USD 0%
Deferred Tax Assets, Operating Loss Carryforwards 26.4M USD -1.06%
Unrecognized Tax Benefits 877K USD 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 275K USD -66.7%
Amortization of Intangible Assets 900K USD -30.8%
Depreciation, Depletion and Amortization 356K USD -54.4%
Deferred Tax Assets, Net of Valuation Allowance 21K USD -96.8%
Share-based Payment Arrangement, Expense 347K USD -40.5%